Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048115441> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W3048115441 abstract "Aim: It remains unclear what the best therapeutic option for recurrent glioma patients after Stupp treatment is. Bevacizumab (BVZ) is commonly administered in progression, but it appears that only some patients benefit. It would be useful to find biomarkers that determine beforehand who these patients are. Methods: The protocol included 31 high-risk progressing glioma patients after Stupp treatment who received BVZ 5-10 mg/kg every 14 days and temozolomide (3-19 cycles, 150-200 mg five days each 28-day cycle) during a mean of eight cycles of BVZ or until tumor progression or unacceptable toxicity. We analyzed the clinical outcome values of inflammatory indices measured before BVZ administration. Results: Lymphocyte level before BVZ administration was the best independent predictor of overall survival (HR = 0.34; 95%CI: 0.145-0.81; P = 0.015). The area under the receiver operating characteristic (ROC) curve was 0.823, with 1.645 being the optimal cut-off value, and 0.80 and 0.85 the sensitivity and specificity values, respectively. Responder and non-responder survival curves were also significantly different, considering the first and second tertiles as cut-off points. The number of BVZ cycles was not related to lymphopenia. Pretreatment neutrophil, platelet levels, platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) did not have independent predictive value. Inflammatory variables were not correlated with each other. However, patients with high NLR and PLR simultaneously (double positive PLR-NLR) showed a worse clinical outcome than the rest (P = 0.043). Conclusion: Pretreatment lymphocyte levels and double positive PLR-NLR could be used as non-invasive hematological prognostic markers for recurrent gliomas treated with bevacizumab. A close relationship emerged between inflammation and angiogenesis." @default.
- W3048115441 created "2020-08-13" @default.
- W3048115441 creator A5002657236 @default.
- W3048115441 creator A5003366839 @default.
- W3048115441 creator A5045145786 @default.
- W3048115441 creator A5065036992 @default.
- W3048115441 date "2020-01-01" @default.
- W3048115441 modified "2023-10-18" @default.
- W3048115441 title "Pretreatment inflammatory indices predict Bevacizumab response in recurrent Glioma" @default.
- W3048115441 cites W1536103630 @default.
- W3048115441 cites W1572358378 @default.
- W3048115441 cites W1880612110 @default.
- W3048115441 cites W1893402990 @default.
- W3048115441 cites W1974511844 @default.
- W3048115441 cites W1976202809 @default.
- W3048115441 cites W1982906652 @default.
- W3048115441 cites W2026049078 @default.
- W3048115441 cites W2042770809 @default.
- W3048115441 cites W2046381431 @default.
- W3048115441 cites W2059948937 @default.
- W3048115441 cites W2061308781 @default.
- W3048115441 cites W2061877558 @default.
- W3048115441 cites W2065374722 @default.
- W3048115441 cites W2067971776 @default.
- W3048115441 cites W2072172607 @default.
- W3048115441 cites W2073425124 @default.
- W3048115441 cites W2074614782 @default.
- W3048115441 cites W2096287682 @default.
- W3048115441 cites W2113522487 @default.
- W3048115441 cites W2115597075 @default.
- W3048115441 cites W2125643269 @default.
- W3048115441 cites W2132697290 @default.
- W3048115441 cites W2158794894 @default.
- W3048115441 cites W2170129724 @default.
- W3048115441 cites W2186036549 @default.
- W3048115441 cites W2302885032 @default.
- W3048115441 cites W2340964024 @default.
- W3048115441 cites W2397092478 @default.
- W3048115441 cites W2464450508 @default.
- W3048115441 cites W2465121181 @default.
- W3048115441 cites W2490669401 @default.
- W3048115441 cites W2515051287 @default.
- W3048115441 cites W2739930313 @default.
- W3048115441 cites W2769014061 @default.
- W3048115441 cites W2921837971 @default.
- W3048115441 cites W3010783275 @default.
- W3048115441 doi "https://doi.org/10.20517/cdr.2020.33" @default.
- W3048115441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35582438" @default.
- W3048115441 hasPublicationYear "2020" @default.
- W3048115441 type Work @default.
- W3048115441 sameAs 3048115441 @default.
- W3048115441 citedByCount "2" @default.
- W3048115441 countsByYear W30481154412021 @default.
- W3048115441 crossrefType "journal-article" @default.
- W3048115441 hasAuthorship W3048115441A5002657236 @default.
- W3048115441 hasAuthorship W3048115441A5003366839 @default.
- W3048115441 hasAuthorship W3048115441A5045145786 @default.
- W3048115441 hasAuthorship W3048115441A5065036992 @default.
- W3048115441 hasBestOaLocation W30481154411 @default.
- W3048115441 hasConcept C126322002 @default.
- W3048115441 hasConcept C143998085 @default.
- W3048115441 hasConcept C2776694085 @default.
- W3048115441 hasConcept C2777389519 @default.
- W3048115441 hasConcept C2777761686 @default.
- W3048115441 hasConcept C2777802072 @default.
- W3048115441 hasConcept C2778227246 @default.
- W3048115441 hasConcept C502942594 @default.
- W3048115441 hasConcept C58471807 @default.
- W3048115441 hasConcept C71924100 @default.
- W3048115441 hasConcept C90924648 @default.
- W3048115441 hasConceptScore W3048115441C126322002 @default.
- W3048115441 hasConceptScore W3048115441C143998085 @default.
- W3048115441 hasConceptScore W3048115441C2776694085 @default.
- W3048115441 hasConceptScore W3048115441C2777389519 @default.
- W3048115441 hasConceptScore W3048115441C2777761686 @default.
- W3048115441 hasConceptScore W3048115441C2777802072 @default.
- W3048115441 hasConceptScore W3048115441C2778227246 @default.
- W3048115441 hasConceptScore W3048115441C502942594 @default.
- W3048115441 hasConceptScore W3048115441C58471807 @default.
- W3048115441 hasConceptScore W3048115441C71924100 @default.
- W3048115441 hasConceptScore W3048115441C90924648 @default.
- W3048115441 hasLocation W30481154411 @default.
- W3048115441 hasLocation W30481154412 @default.
- W3048115441 hasLocation W30481154413 @default.
- W3048115441 hasOpenAccess W3048115441 @default.
- W3048115441 hasPrimaryLocation W30481154411 @default.
- W3048115441 hasRelatedWork W2004862885 @default.
- W3048115441 hasRelatedWork W2010993787 @default.
- W3048115441 hasRelatedWork W2013021062 @default.
- W3048115441 hasRelatedWork W2079914139 @default.
- W3048115441 hasRelatedWork W2088650889 @default.
- W3048115441 hasRelatedWork W2462822954 @default.
- W3048115441 hasRelatedWork W2527516493 @default.
- W3048115441 hasRelatedWork W3004632817 @default.
- W3048115441 hasRelatedWork W3216112740 @default.
- W3048115441 hasRelatedWork W4385277635 @default.
- W3048115441 isParatext "false" @default.
- W3048115441 isRetracted "false" @default.
- W3048115441 magId "3048115441" @default.
- W3048115441 workType "article" @default.